These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. Hohmann J; Skrok J; Puls R; Albrecht T Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698 [TBL] [Abstract][Full Text] [Related]
4. Characterizing benign liver lesions and trauma with contrast-enhanced ultrasound. Wills M; Harvey CJ; Kuzmich S; Afaq A; Lim A; Cosgrove D Br J Hosp Med (Lond); 2014 Feb; 75(2):91-5. PubMed ID: 24521804 [TBL] [Abstract][Full Text] [Related]
9. Imaging of focal liver lesions: the 90 %-rule. Mostbeck G Ultraschall Med; 2010 Dec; 31(6):545-7. PubMed ID: 21117006 [No Abstract] [Full Text] [Related]
10. The role of real-time contrast-enhanced and real-time virtual sonography in the assessment of malignant liver lesions. Sandulescu L; Saftoiu A; Dumitrescu D; Ciurea T J Gastrointestin Liver Dis; 2009 Mar; 18(1):103-8. PubMed ID: 19337645 [TBL] [Abstract][Full Text] [Related]
11. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314 [TBL] [Abstract][Full Text] [Related]
12. Imaging of paediatric liver tumours with pathological correlation. Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008 [TBL] [Abstract][Full Text] [Related]
13. Imaging of nontraumatic hemorrhagic hepatic lesions. Casillas VJ; Amendola MA; Gascue A; Pinnar N; Levi JU; Perez JM Radiographics; 2000; 20(2):367-78. PubMed ID: 10715337 [TBL] [Abstract][Full Text] [Related]
14. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. Trillaud H; Bruel JM; Valette PJ; Vilgrain V; Schmutz G; Oyen R; Jakubowski W; Danes J; Valek V; Greis C World J Gastroenterol; 2009 Aug; 15(30):3748-56. PubMed ID: 19673015 [TBL] [Abstract][Full Text] [Related]
15. [Focal liver lesion, incidental finding]. Dietrich CF; Jenssen C Dtsch Med Wochenschr; 2012 Oct; 137(41):2099-116. PubMed ID: 23033169 [TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos. Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670 [TBL] [Abstract][Full Text] [Related]
18. Benign liver masses: imaging with microbubble contrast agents. Kim TK; Jang HJ; Wilson SR Ultrasound Q; 2006 Mar; 22(1):31-9. PubMed ID: 16641791 [TBL] [Abstract][Full Text] [Related]
19. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944 [TBL] [Abstract][Full Text] [Related]
20. The ins and outs of liver imaging. O'Neill EK; Cogley JR; Miller FH Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]